IN158843B - - Google Patents

Info

Publication number
IN158843B
IN158843B IN848/DEL/82A IN848DE1982A IN158843B IN 158843 B IN158843 B IN 158843B IN 848DE1982 A IN848DE1982 A IN 848DE1982A IN 158843 B IN158843 B IN 158843B
Authority
IN
India
Prior art keywords
radical
hydrogen
lower alkyl
derivatives
phenyl radical
Prior art date
Application number
IN848/DEL/82A
Other languages
English (en)
Inventor
Philippe Briet
Jean-Jacques Berthelon
Francois Collonges
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of IN158843B publication Critical patent/IN158843B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN848/DEL/82A 1981-11-25 1982-11-18 IN158843B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8122020A FR2516922A1 (fr) 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant

Publications (1)

Publication Number Publication Date
IN158843B true IN158843B (es) 1987-01-31

Family

ID=9264332

Family Applications (1)

Application Number Title Priority Date Filing Date
IN848/DEL/82A IN158843B (es) 1981-11-25 1982-11-18

Country Status (24)

Country Link
US (2) US4602034A (es)
EP (1) EP0080934B1 (es)
JP (1) JPS5896082A (es)
AT (1) ATE31927T1 (es)
AU (1) AU563190B2 (es)
CA (1) CA1213595A (es)
CS (1) CS248035B2 (es)
DD (1) DD204919A5 (es)
DE (1) DE3277970D1 (es)
DK (1) DK164163C (es)
ES (1) ES8308323A1 (es)
FR (1) FR2516922A1 (es)
HU (1) HU192112B (es)
IE (1) IE54130B1 (es)
IL (1) IL67291A0 (es)
IN (1) IN158843B (es)
MA (1) MA19650A1 (es)
MX (1) MX173498B (es)
NO (1) NO159169C (es)
NZ (1) NZ202596A (es)
OA (1) OA07257A (es)
SU (1) SU1250171A3 (es)
YU (2) YU43726B (es)
ZA (1) ZA828436B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536397A2 (en) * 1981-11-25 1984-05-25 Lipha [4-oxo-4H-1-Benzopyran-8-yl]alkanoic acids, their salts and derivatives, their preparation and medicinal products containing them
DE3311004A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromon-8-aldehyde, sowie ein verfahren zu ihrer herstellung
JPS62215581A (ja) * 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
IL85554A0 (en) * 1987-03-02 1988-08-31 Takeda Chemical Industries Ltd Chromone derivatives
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
IL89840A (en) * 1988-04-06 1996-10-31 Lipha Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them
US5116954A (en) * 1988-04-06 1992-05-26 Lipha, Lyonnaise Industrielle Pharmaceutique Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety
US5126129A (en) * 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
US5238954A (en) * 1989-01-19 1993-08-24 The Upjohn Company Fluorinated flavone acetic acid
AU4847390A (en) * 1989-01-19 1990-08-13 Upjohn Company, The Fluorinated flavone acetic acid
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
ATE324888T1 (de) * 1999-06-14 2006-06-15 Cancer Rec Tech Ltd Krebstherapie
CA2389924A1 (en) 2000-01-24 2001-07-26 Jozef S. Mruk Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes
JP2004505047A (ja) * 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) * 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) * 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) * 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
GB0321999D0 (en) * 2003-09-19 2003-10-22 Cancer Rec Tech Ltd Anti-cancer combinations
WO2007023302A1 (en) * 2005-08-26 2007-03-01 Antisoma Plc Combinations comprising dmxaa for the treatment of cancer
WO2011023287A1 (en) 2009-08-27 2011-03-03 Merck Patent Gmbh Use of faa and its derivatives in cosmetics and dermatology
KR101821768B1 (ko) 2009-11-05 2018-01-24 리젠 파마슈티컬스 소시에떼 아노님 신규한 벤조피란 키나제 조절제
CN103304531A (zh) * 2013-06-25 2013-09-18 南方医科大学 一种3-芳基黄酮乙酸
KR20180120746A (ko) * 2016-03-11 2018-11-06 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 이카리인 및 이카리틴 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US3350411A (en) * 1963-10-10 1967-10-31 Pharma Seceph S A Soc D Expl C Process for preparing 3-methylflavone-8-carboxylic acid
BE757821A (fr) * 1970-08-01 1971-04-01 Recordati Chem Pharm Procede de preparation de l'acide 3-propionyl-salicylique et dederives de cet acide
GB1479518A (en) * 1973-12-27 1977-07-13 Erba Carlo Spa 5,6-benzo-ypsilon-pyrone derivatives
US4148900A (en) * 1973-12-27 1979-04-10 Carlo Erba S.P.A. 5:6-Benzo-γ-pyrone derivatives and process for their preparation
FR2281112A1 (fr) * 1974-08-05 1976-03-05 Lipha Nouveau medicament choleretique et anti-inflammatoire
GB1469823A (en) * 1974-08-13 1977-04-06 Farma Lepori Flavone derivatives
DE2549745A1 (de) * 1974-11-20 1976-05-26 Lipha Durch einen chromonylrest substituierte propionsaeuren sowie deren derivate und verwendungen

Also Published As

Publication number Publication date
DK164163C (da) 1992-10-19
ZA828436B (en) 1983-09-28
SU1250171A3 (ru) 1986-08-07
OA07257A (fr) 1984-04-30
AU9073082A (en) 1983-06-02
JPH0214352B2 (es) 1990-04-06
JPS5896082A (ja) 1983-06-07
US4783533A (en) 1988-11-08
DD204919A5 (de) 1983-12-14
ATE31927T1 (de) 1988-01-15
YU264982A (en) 1984-12-31
MX173498B (es) 1994-03-10
EP0080934A1 (fr) 1983-06-08
IE54130B1 (en) 1989-06-21
NZ202596A (en) 1986-02-21
FR2516922B1 (es) 1984-02-10
ES517637A0 (es) 1983-08-16
EP0080934B1 (fr) 1988-01-13
DE3277970D1 (en) 1988-02-18
NO159169B (no) 1988-08-29
FR2516922A1 (fr) 1983-05-27
YU43726B (en) 1989-10-31
CA1213595A (fr) 1986-11-04
CS248035B2 (en) 1987-01-15
YU163084A (en) 1985-03-20
HU192112B (en) 1987-05-28
IL67291A0 (en) 1983-03-31
DK523082A (da) 1983-05-26
IE822752L (en) 1983-05-25
YU43675B (en) 1989-10-31
MA19650A1 (fr) 1983-07-01
AU563190B2 (en) 1987-07-02
ES8308323A1 (es) 1983-08-16
US4602034A (en) 1986-07-22
NO159169C (no) 1988-12-07
NO823940L (no) 1983-05-26
DK164163B (da) 1992-05-18

Similar Documents

Publication Publication Date Title
IN158843B (es)
ZA817696B (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alcanoic acids,salts and esters thereof,process for producing the same and these active agents containing pharmaceutical compounds
DE3372287D1 (en) Process for the preparation of tetrahydropyridines
JPS54154760A (en) Lactammnnacetic acid or its amide and said manufacture
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
DK240184D0 (da) Beta-carboline-3-carboxylic acid derivatives and method of preparing the same
GB1122879A (en) Substituted 2-alkylidene acetic acids and their derivatives
EP0395528A3 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
PT72401A (en) Process for the preparation of an insecticidal and/or acaricidal composition containing esters of substituted 3-(1,2-dibromoalkyl)-2,2-dimethyl cyclopropan-1-carboxylic acids
AU546507B2 (en) Acylated furanyl
PT72340A (en) Process for the preparation of a fungicidal composition containing esters of indan-4-yl of n-alkyl-carbamic acids
ES8503646A1 (es) Procedimiento para la obtencion de derivados de bencilurea.
GB1042482A (en) Diamides
ES402968A1 (es) Procedimiento para la preparacion de esteres mixtos de 2,6-piridindimetanol.
ES8201996A1 (es) Procedimiento para la preparacion de acidos 2,4-diamino-5- sulfamoilbenzosulfonicos sustituidos